Company / Total Debt
Arcus Biosciences, Inc. Total Debt History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$99.0M
FY2025
5-year range
$0 / $99.0M
FY2023-FY2025
Trend
+106.3%
vs FY2024
Sector context
#60 of 83
Health Care
What the data says
At $99M, Arcus Biosciences, Inc.'s total debt ranks #24 of 83 in the Health Care sector. Increased from $0 to $99M over the past 2 years.
Based on SEC 10-K filings.
$99M in FY2025.
Increased from $0 to $99M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#24 of 83 in Health CareTop 28% of 83This company $99.0M Sector average $6.2B
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, total debt increased 106.3% year-over-year.
- Ranks #60 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $99.0M | +106.3% |
| FY2024 | $48.0M | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026